PIMA542172
Mirikizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA542172-Each-of-1 | In Stock | ₹ 45,646.26 |
PIMA542172 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,646.26
GST (18%): ₹ 8,216.327
Total Price: ₹ 53,862.587
Antigen
Mirikizumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
LY-3074828
Immunogen
Human IL23A
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
1.76 mg/mL
Formulation
PBS with no preservative; pH 7.5
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG4 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Mirikizumab is a humanized IgG4 monoclonal antibody that targets p19 subunit of IL-23
- Currently, mirikizumab is being developed for a variety of immune diseases, including psoriasis, UC, and Crohn's disease (CD)
- Among them, the treatment of moderate to severe plaque psoriasis is in phase III clinical trials.
Compare Similar Items
Show Difference
Antigen: Mirikizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: LY-3074828
Immunogen: Human IL23A
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.76 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Mirikizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
LY-3074828
Immunogen:
Human IL23A
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.76 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Bemarituzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: FPA114-A; FPA-144
Immunogen: Human FGFR2
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.13 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Bemarituzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
FPA114-A; FPA-144
Immunogen:
Human FGFR2
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.13 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Zenocutuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: MCLA-128; PB4188; R040517
Immunogen: Human ERBB2/ERBB3
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1.96 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Zenocutuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
MCLA-128; PB4188; R040517
Immunogen:
Human ERBB2/ERBB3
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1.96 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ
Antigen: Tibulizumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: LY 3090106; LY3090106; LY-3090106
Immunogen: Human IL17A/TNFSF13B/CD257
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Tibulizumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
LY 3090106; LY3090106; LY-3090106
Immunogen:
Human IL17A/TNFSF13B/CD257
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ